Position in ABVX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$75,074,286
+$22,410,079 QoQ
Shares Held
563,367
+19.1% QoQ
Ownership
0.646%
of shares outstanding
% of Portfolio
1.51%
of 13F equity value
Holder Rank
#26
of 302 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ABVX Over Time
Shares Held
Position Value (USD)
Derivatives in ABVX
reported options exposure · as of Jun 30, 2026CallValue
$14,445,384
CallShares
108,400
PutValue
$10,221,042
PutShares
76,700
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BOOTHBAY FUND MANAGEMENT, LLC holds $665,103,201 across 158 Biotechnology names. ABVX ranks #2 (11.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
465,787 | $87,232,589 | |
| 2 | ABVX |
Abivax S.A.
This page
|
563,367 | $75,074,286 | |
| 3 | EXEL |
Exelixis, Inc.
|
804,095 | $43,750,808 | |
| 4 | PCVX |
Vaxcyte, Inc.
|
534,163 | $31,050,895 | |
| 5 | COGT |
Cogent Biosciences, Inc.
|
692,825 | $26,812,327 | |
| 6 | CGEM |
Cullinan Therapeutics, Inc.
|
1,082,611 | $19,714,346 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
500,497 | $15,645,536 | |
| 8 | AVTX |
Avalo Therapeutics, Inc.
|
702,051 | $12,973,902 |
All Filings in ABVX
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,221,042 | 76,700 | Put | Other | 2026-08-14 | |
| 2026-06-30 | $14,445,384 | 108,400 | Call | Other | 2026-08-14 | |
| 2026-06-30 | $75,074,286 | 563,367 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $52,664,207 | 472,961 | Shares | Other | 2026-05-15 | |
| 2026-03-31 | $9,609,505 | 86,300 | Call | Other | 2026-05-15 | |
| 2025-12-31 | $4,760,381 | 35,300 | Call | Other | 2026-02-17 | |
| 2025-12-31 | $68,490,292 | 507,881 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $50,764,341 | 597,931 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $6,658,850 | 870,438 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $3,566,675 | 570,668 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $2,978,529 | 406,903 | Shares | Other | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||